sever
acut
respiratori
syndrom
sar
respiratori
diseas
caus
newli
found
viru
call
sar
coronaviru
studi
cleavag
mechan
sar
coronaviru
main
proteinas
pro
pro
octapeptid
nh
avlq
fl
sgfrcooh
investig
use
molecular
mechan
quantum
mechan
simul
base
experiment
structur
proteinas
observ
catalyt
dyad
site
domain
ii
attract
p
electron
densiti
peptid
bond
glnser
increas
posit
charg
c
co
gln
neg
charg
n
nh
ser
weaken
glnser
peptid
bond
catalyt
function
group
imidazol
group
n
imidazol
ring
play
acidbas
catalyt
role
base
distort
key
theori
kc
chou
anal
biochem
possibl
convert
octapeptid
compet
inhibitor
studi
found
chemic
bond
gln
ser
becom
much
stronger
longer
cleavabl
sar
enzym
either
chang
carbonyl
group
co
gln
ch
cf
chang
nh
ser
ch
cf
octapeptid
thu
modifi
might
becom
effect
inhibitor
potenti
drug
candid
sar
nucleotid
replicas
gene
alon
encompass
nucleotid
whole
genom
sequenc
replicas
gene
encod
two
overlap
polyprotein
aa
aa
sar
cov
main
proteinas
pro
cleav
polyprotein
less
conserv
site
process
initi
autolyt
cleavag
releas
polypeptid
mediat
function
requir
sar
viral
replic
transcript
function
import
pro
see
front
matter
elsevi
inc
right
reserv
viral
life
cycl
make
attract
target
drug
design
sar
anand
et
al
suggest
rhinoviru
pro
inhibitor
could
well
serv
start
point
antisar
drug
base
theoret
homolog
model
sar
cov
pro
chou
et
al
found
fit
problem
bind
pocket
sar
cov
pro
suggest
deriv
better
start
point
siroi
et
al
virtual
screen
sarscov
proteas
base
pharmacophor
point
chou
et
al
also
suggest
octapeptid
nh
avlq
fl
sgfrcooh
convert
inhibitor
sar
cov
pro
chemic
modif
octapeptid
synthes
prove
cleavabl
peptid
show
strong
inhibit
activ
tube
test
du
et
al
analyz
cleavag
mechan
octapeptid
sar
cov
pro
discuss
possibl
chemic
modif
octapeptid
use
molecular
dynam
quantum
mechan
simul
base
homolog
structur
sar
cov
pro
convert
stabl
effect
drug
progress
find
inhibitor
sar
enzym
also
summar
recent
review
experiment
structur
sar
cov
pro
first
determin
research
group
provid
sever
crystal
structur
sar
cov
pro
differ
ph
condit
complex
structur
sar
cov
pro
ligand
hexapeptidyl
cmk
experiment
structur
theoret
homolog
structur
sar
cov
pro
share
mani
structur
similar
catalyt
activ
region
cyshi
cleavag
dyad
howev
sever
differ
theoret
experiment
structur
exampl
experiment
structur
sar
cov
pro
dimer
protom
catalyt
activ
protom
b
activ
howev
n
finger
protom
b
plug
activ
cleft
protom
play
import
role
dimer
mainten
activ
form
enzym
new
find
experiment
structur
sar
cov
pro
provid
reliabl
basi
inhibitor
design
octapeptid
nh
avlq
fl
sgfrcooh
show
strong
inhibit
activ
vitro
howev
use
nativ
peptid
clinic
applic
hamper
intrins
metabol
instabl
indigest
enzym
poor
absorpt
membran
cleavabl
peptid
sar
cov
pro
mean
possess
compet
bind
receptor
breakabl
peptid
bond
cleavag
site
convert
cleavabl
peptid
stabl
effect
inhibitor
peptid
modifi
accord
distort
key
theori
one
import
step
chemic
modif
good
understand
cleavag
mechan
particularli
chang
chemic
bond
proteasesuscept
site
given
protein
peptid
usual
extend
octapeptid
region
correspond
amino
acid
residu
sequenti
symbol
eight
subsit
r
r
r
r
r
r
r
r
eight
match
posit
proteas
respect
see
fig
occasion
suscept
site
protein
may
contain
one
subsit
less
one
howev
eight
amino
acid
residu
common
case
although
protein
cleav
contain
much
eight
amino
acid
residu
octapeptid
segment
fit
activ
region
proteas
therefor
research
focu
cleavabl
octapeptid
shown
fig
cleavag
point
alway
peptid
bond
r
r
fig
use
combin
thin
line
dash
line
repres
conjug
p
properti
peptid
bond
fig
breakabl
peptid
bond
r
r
convert
strong
hybrid
peptid
bond
chemic
modif
henc
cleav
proteas
modifi
octapeptid
still
bind
activ
site
cleav
enzym
like
distort
key
neither
open
lock
pull
octapeptid
thu
modifi
automat
becom
desir
inhibitor
candid
octapeptid
avlqsgfr
first
suggest
base
molecular
structur
sar
cov
pro
prove
cleavabl
experi
research
studi
cleavag
mechan
properti
relev
chemic
bond
catalyt
interact
octapeptid
sar
cov
pro
use
molecular
mechan
quantum
chemic
simul
provid
use
insight
chemic
modif
studi
carri
follow
four
step
dock
octapeptid
sar
cov
pro
follow
energi
minim
complex
structur
use
molecular
mechan
comput
atom
charg
distribut
bind
pocket
energyminim
structur
use
ab
initio
quantum
mechan
comput
molecular
energi
chemic
bond
properti
atom
charg
octapeptid
background
charg
distribut
sar
cov
pro
use
ab
initio
quantum
chemistri
background
charg
distribut
comput
molecular
energi
chemic
bond
properti
atom
charg
modifi
octapeptid
comput
carri
molecular
dynam
standard
ab
initio
quantum
chemistri
level
experiment
structur
sar
cov
pro
use
calcul
shown
fig
protom
structur
sar
cov
pro
dimer
three
domain
two
protom
b
form
right
angl
join
part
domain
iii
n
finger
protom
b
plug
domain
ii
protom
play
import
role
catalyt
activ
pdb
data
sar
cov
pro
contain
hydrat
water
molecul
provid
solvat
ion
environ
water
molecul
join
catalyt
reaction
fig
green
sign
repres
solvat
water
molecul
dock
calcul
sar
cov
pro
octapeptid
avlqsgfr
perform
use
molecular
although
still
bound
activ
site
peptid
lost
cleavabl
scissil
bond
modifi
hybrid
peptid
bond
strong
bond
adapt
chou
permiss
oper
environ
program
packag
total
dock
conform
obtain
one
lowest
energi
use
energi
minim
calcul
fig
show
complex
structur
sar
cov
pro
ligand
octapeptid
posit
catalyt
dyad
indic
fig
accord
anand
et
al
yang
et
al
chou
et
al
catalyt
activ
region
pocket
domain
ii
protom
calcul
catalyt
activ
region
focus
contain
amino
acid
residu
promot
residu
promot
b
practic
calcul
actual
region
involv
contain
much
abovelist
amino
acid
residu
includ
amino
acid
residu
within
surround
octapeptid
water
molecul
play
import
role
proteolyt
reaction
result
deriv
complex
structur
obtain
follow
aforement
dock
energyminim
procedur
hydrophil
hydrophob
complementari
interact
import
ligandreceptor
interact
accord
sphere
model
activ
region
proteinas
consist
seri
sphere
interact
site
ligand
receptor
contain
one
sphere
must
least
one
hydrophob
interact
site
fig
b
hydrophil
hydrophob
surfac
octapeptid
avlqsgfr
catalyt
activ
region
sar
cov
pro
respect
figur
green
part
hydrophob
surfac
blue
part
hydrophil
surfac
good
hydrophil
hydrophob
complementari
interact
ligand
receptor
hydrophil
part
ligand
correspond
hydrophil
part
receptor
hydrophob
part
ligand
correspond
hydrophob
part
receptor
octapeptid
nh
avlq
fl
sgfrcooh
four
hydrophob
amino
acid
residu
ala
val
phe
arg
among
ala
val
expos
solvent
phe
arg
cover
hydrophob
surfac
proteinas
peptid
bond
cleav
gln
ser
join
point
expos
part
cover
part
calcul
focus
effect
sar
cov
pro
peptid
bond
cleav
properli
treat
biomacromolecul
solvent
effect
nontrivi
problem
quantum
chemic
calcul
electrostat
interact
play
domin
role
ligandreceptor
combin
must
taken
account
quantum
mechan
studi
view
treat
sar
cov
pro
background
mani
point
charg
amino
acid
residu
catalyt
region
domain
ii
protom
divid
seven
segment
atom
charg
separ
calcul
use
ab
initio
quantum
chemic
method
amino
acid
residu
n
finger
protom
b
taken
account
also
amino
acid
residu
eight
segment
list
tabl
atom
charg
background
includ
atom
catalyt
cleft
overlap
atom
count
anoth
difficult
problem
quantum
mechan
calcul
biolog
system
solut
solvent
effect
pdb
data
sar
cov
pro
solvat
water
molecul
water
molecul
provid
solvat
environ
also
indic
water
molecul
involv
catalyt
reaction
calcul
solvat
water
molecul
treat
background
charg
water
molecul
point
charg
therefor
background
point
charg
tabl
list
mulliken
atom
charg
q
mull
electrostat
potenti
equival
charg
q
esp
obtain
fit
atom
charg
electrostat
potenti
van
der
waal
surfac
atom
charg
semiempir
method
quit
differ
result
ab
initio
particular
q
esp
charg
appear
reason
q
esp
charg
reproduc
quantum
mechan
electrostat
potenti
molecular
surfac
research
use
q
esp
calcul
illustr
point
imidazol
group
nucleophil
agent
pk
near
concentr
proton
h
pure
water
imidazol
ring
proton
donor
receptor
good
catalyt
activ
physiolog
condit
seen
tabl
neg
charg
n
posit
charg
h
larg
magnitud
close
peptid
bond
glnser
therefor
proton
h
attract
p
electron
densiti
peptid
bond
glnser
weaken
chemic
bond
polar
nitrogen
n
attract
one
hydrogen
h
bridg
water
make
water
molecul
dissoci
caus
nucleophil
attack
hydroxyl
group
oh
c
co
electrophil
attack
h
n
nh
two
side
peptid
bond
glnser
sulfur
atom
form
hydrogen
bond
h
nh
help
proteolyt
reaction
fig
peptid
bond
consid
pseudo
p
bond
six
atom
peptid
bond
gln
ca
conhca
ser
almost
plane
fig
show
electron
densiti
contour
map
peptid
bond
glnser
gaseou
phase
p
plane
contain
carbonyl
group
co
gln
nh
group
ser
electron
densiti
contour
surround
atom
n
nh
c
co
form
two
triangl
reminisc
hybrid
orbit
sp
type
z
orbit
perpendicular
plane
form
p
bond
system
tabl
list
calcul
atom
charg
six
atom
side
peptid
bond
glnser
obtain
ab
initio
calcul
gaseou
phase
background
charg
sarscov
pro
neg
charg
n
nh
serin
octapeptid
increas
background
proteinas
charg
origin
valu
gaseou
phase
similarli
correspond
posit
charg
carbonyl
carbon
c
co
glutamin
octapeptid
increas
origin
favor
electrophil
attack
oh
c
co
nucleophil
attack
h
n
nh
proteolyt
reaction
fig
contour
map
differenti
electron
densiti
peptid
bond
glnser
octapeptid
avlqsgfr
obtain
subtract
electron
densiti
gaseou
phase
electron
densiti
background
sar
cov
pro
solvent
water
molecul
fig
bold
gray
line
valu
line
electron
densiti
gaseou
phase
proteas
background
equal
solid
thin
line
show
region
comput
electron
densiti
greater
sar
cov
pro
background
gaseou
phase
dash
thin
line
show
area
comput
electron
densiti
smaller
proteinas
background
gaseou
phase
find
along
peptid
bond
gln
cn
ser
electron
densiti
increas
n
ser
side
decreas
c
gln
side
chang
favor
nucleophil
attack
anion
oh
gln
c
electrophil
attack
cation
h
n
ser
sar
cov
pro
high
cleavag
specif
highli
conserv
coronaviru
famili
cleavag
specif
sar
cov
pro
concentr
site
develop
peptid
clinic
use
drug
limit
poor
stabil
bioavail
due
part
inabl
readili
cross
membran
barrier
intestin
bloodbrain
barrier
systemat
chemic
modif
strategi
convert
peptid
drug
attract
research
topic
current
medicin
chemistri
peptid
inhibitor
proteinas
chemic
modif
cleavabl
octapeptid
focu
scissil
peptid
bond
r
r
cleav
sar
cov
pro
success
exampl
show
peptid
bond
co
nh
replac
reduc
singl
bond
ch
anh
modifi
octapeptid
rennin
inhibitor
shown
greatli
increas
affin
rennin
strong
resist
enzym
hydrolysi
studi
suggest
similar
modif
octapeptid
avlqsgfr
peptid
bond
gln
co
nh
ser
carboxyl
group
co
glutamin
subsit
r
replac
ch
cf
nh
serin
subsit
r
replac
ch
p
bond
system
broken
modifi
octapeptid
avlq
sgfr
may
becom
stabl
inhibitor
sarscov
pro
effect
drug
candid
sar
show
possibl
chemic
modif
comput
model
tabl
list
atom
charg
six
atom
side
hybrid
peptid
bond
glnser
chemic
modif
compar
tabl
find
co
replac
ch
charg
carbon
atom
ch
turn
neg
origin
posit
valu
co
group
henc
nucleophil
attack
oh
becom
imposs
furthermor
neg
charg
n
nh
ser
side
decreas
tabl
henc
electrophil
attack
h
also
becom
difficult
likewis
modif
co
fi
cf
nh
fi
ch
make
proteolyt
reaction
difficult
also
search
cleavabl
peptid
first
step
find
potenti
inhibitor
proteinas
even
within
limit
rang
octapeptid
mean
easi
job
possibl
differ
pattern
octapeptid
mani
howev
algorithm
vector
sequencecoupl
algorithm
discrimin
function
algorithm
success
use
narrow
search
scope
meanwhil
similar
method
use
search
cleavabl
peptid
sar
enzym
develop
octapeptid
nh
alavalleuglnserglypheargcooh
first
design
basi
molecular
structur
sarscov
pro
experiment
demonstr
cleavabl
peptid
high
bioactiv
detail
studi
cleavag
mechan
need
great
deal
experiment
work
howev
comput
simul
may
provid
use
insight
indepth
understand
mechan
cleavabl
octapeptid
could
chang
effect
inhibitor
sarscov
pro
drug
candid
sar
proper
chemic
modif
replac
cleavabl
peptid
bond
noncleav
bond
octapeptid
thu
modifi
lose
suscept
although
still
tightli
bind
activ
site
becom
compet
inhibitor
like
role
distort
key
block
access
key
lock
elucid
chou
review
paper
